<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>11468789</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Balboa, A</dc:author>
<dc:author>Mearin, F</dc:author>
<dc:description xml:lang="en">In summary, in light of the flood of figures, statistics, and epidemiological evidence, the socioeconomic importance of IBS cannot be questioned. The development of new, effective treatments that would control the symptoms is a huge challenge for researchers and the pharmaceutical industry. Drugs able to relieve the symptoms of IBS would provide great relief to a large number of patients, and would save the health system considerable effort and resources.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Dec </dc:date>
<dc:title xml:lang="en">Epidemiological characteristics and socioeconomic importance of irritable bowel syndrome.</dc:title>
<dc:publisher>Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva</dc:publisher>
</metadata>
</record>
</pubmed-document>
